The changing face of treatment for metastatic colorectal cancer.

作者: Per Pfeiffer , Claus-Henning Köhne , Camilla Qvortrup

DOI: 10.1080/14737140.2019.1543593

关键词: Triplet chemotherapyPersonalized therapyTreatment strategyChemotherapyMedicineColorectal cancerIntensive care medicineTargeted therapy

摘要: ABSTRACTIntroduction: Since late 1990’s therapy of metastatic colorectal cancer (mCRC) patients has changed considerable, and the combination doublet or triplet chemotherapy a targeted agent are now routinely used. With introduction more intensified regimens, it become even important to identify that will benefit from can tolerate therapy. Furthermore, increasing understanding biology mCRC led discovery new potential targets. Therefore, with undergone considerable change ‘one strategy fits all’ towards personalized therapy.Areas covered: We present an overview recent literature on approved systemic treatment however focus how based clinical molecular parameters presently used in situation.Expert commentary: The face approach ...

参考文章(89)
Halfdan Sorbye, Anca Dragomir, Magnus Sundström, Per Pfeiffer, Ulf Thunberg, Monica Bergfors, Kristine Aasebø, Geir Egil Eide, Fredrik Ponten, Camilla Qvortrup, Bengt Glimelius, High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0131046
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
A F Sobrero, C Aschele, J R Bertino, Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation. Journal of Clinical Oncology. ,vol. 15, pp. 368- 381 ,(1997) , 10.1200/JCO.1997.15.1.368
M.E. Kelly, G. Spolverato, G.N. Lê, M.N. Mavros, F. Doyle, T.M. Pawlik, D.C. Winter, Synchronous colorectal liver metastasis: a network meta-analysis review comparing classical, combined, and liver-first surgical strategies Journal of Surgical Oncology. ,vol. 111, pp. 341- 351 ,(2015) , 10.1002/JSO.23819
Feriyl Bhaijee, Thomas Huebner, Ralph H. Hruban, Laura D. Wood, Nathan Cuka, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, Shibin Zhou, Toby C. Cornish, Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Diaz, Dung T. Le, Jennifer N. Uram, Hao Wang, Bjarne R. Bartlett, Holly Kemberling, Aleksandra D. Eyring, Andrew D. Skora, Brandon S. Luber, Nilofer S. Azad, Dan Laheru, Barbara Biedrzycki, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Steven M. Duffy, Richard M. Goldberg, Albert de la Chapelle, Minori Koshiji, PD-1 Blockade in Tumors with Mismatch-Repair Deficiency The New England Journal of Medicine. ,vol. 372, pp. 2509- 2520 ,(2015) , 10.1056/NEJMOA1500596
Gunnar Folprecht, Susanne Hamann, Katharina Schütte, Tanja Trarbach, Jan Stoehlmacher-Williams, Gerhard Ehninger, Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer BMC Cancer. ,vol. 14, pp. 521- 521 ,(2014) , 10.1186/1471-2407-14-521
C.H. Köhne, R. Labianca, T. Price, W. Scheithauer, A. Sobrero, J. Tabernero, D. Aderka, S. Barroso, G. Bodoky, J.Y. Douillard, H. El Ghazaly, J. Gallardo, A. Garin, R. Glynne-Jones, K. Jordan, A. Meshcheryakov, D. Papamichail, P. Pfeiffer, I. Souglakos, S. Turhal, A. Cervantes, H.J. Schmoll, E. Van Cutsem, A. Stein, V. Valentini, B. Glimelius, K. Haustermans, B. Nordlinger, C.J. van de Velde, J. Balmana, J. Regula, I.D. Nagtegaal, R.G. Beets-Tan, D. Arnold, F. Ciardiello, P. Hoff, D. Kerr, ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making Annals of Oncology. ,vol. 23, pp. 2479- 2516 ,(2012) , 10.1093/ANNONC/MDS236
Michelle Shayne, Eva Culakova, Marek S. Poniewierski, Debra Wolff, David C. Dale, Jeffrey Crawford, Gary H. Lyman, Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy Cancer. ,vol. 110, pp. 1611- 1620 ,(2007) , 10.1002/CNCR.22939
Chung-Yuan Hu, Christina E. Bailey, Y. Nancy You, John M. Skibber, Miguel A. Rodriguez-Bigas, Barry W. Feig, George J. Chang, Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. JAMA Surgery. ,vol. 150, pp. 245- 251 ,(2015) , 10.1001/JAMASURG.2014.2253
Daniel B. Longley, D. Paul Harkin, Patrick G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies Nature Reviews Cancer. ,vol. 3, pp. 330- 338 ,(2003) , 10.1038/NRC1074